Citation format for publications in HBSN (2012-2015)

Published: 2015-10-26
Publications in 2012
1. Bengmark S: Nutrition of the critically ill - emphasis on liver and pancreas. Hepatobiliary Surg Nutr 2012, 1:25-52.

2. Du S, Li Y, Mao Y, Sang X, Lu X, Wang W, Zhang Q, Xue H, Yang X, Li S, et al: Diagnosis and treatment of hepatic angiomyolipoma. Hepatobiliary Surg Nutr 2012, 1:19-24.

3. Du S, Zhu L, Sang X, Mao Y, Lu X, Zhong S, Huang J: Gallbladder carcinoma post gallbladder-preserving cholecystolithotomy: a case report. Hepatobiliary Surg Nutr 2012, 1:61-63.

4. Fisher SB, Fisher KE, Maithel SK: Molecular targeted therapy for biliary tract malignancy: defining the target. Hepatobiliary Surg Nutr 2012, 1:53-54.

5. Im JH, Muschel RJ: New evidence of lncRNA role in tumor progression and metastasis. Hepatobiliary Surg Nutr 2012, 1:55-56.

6. Lee KH, Wu CJ, Wang CC, Hung JH: Prevention of chronic HBV infection induced hepatocellular carcinoma development by using antiplatelet drugs. Hepatobiliary Surg Nutr 2012, 1:57-58.

7. Mao Y: HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief. Hepatobiliary Surg Nutr 2012, 1:1.

8. Matsuda K: Novel susceptibility loci for hepatocellular carcinoma in chronic HBV carriers. Hepatobiliary Surg Nutr 2012, 1:59-60.

9. Ye Q, Lian F, Chavez PR, Chung J, Ling W, Qin H, Seitz HK, Wang XD: Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats. Hepatobiliary Surg Nutr 2012, 1:5-18.

10. Zhong S: Some issues regarding the development of general surgery during the last half century. Hepatobiliary Surg Nutr 2012, 1:2-4.

Publications in 2013
11. The Transplantation Society embraces the national program for diseased organ donation in China: "TTS President Francis L. Delmonico"s China Trip. Hepatobiliary Surg Nutr 2013, 2:319-320.

12. OTC Hangzhou Resolution. Hepatobiliary Surg Nutr 2013, 2:317-318.

13. Hangzhou Resolution announcement ceremony. Hepatobiliary Surg Nutr 2013, 2:316.

14. Abradelo M, Jimenez C: Splitting liver grafts for two adults: suboptimal grafts or suboptimal matching? Hepatobiliary Surg Nutr 2013, 2:242-243.

15. Boyko VV, Skoryi DI, Maloshtan OV, Tyshchenko OM, Kozlova TV, Maloshtan AO: Gas jet transection of liver parenchima: experimental research. Hepatobiliary Surg Nutr 2013, 2:156-161.

16. Byam J, Renz J, Millis JM: Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:22-30.

17. Cabibbo G, Petta S, Camma C: Chemoprevention for hepatocellular carcinoma: the role of statins. Hepatobiliary Surg Nutr 2013, 2:1-3.

18. Cardinale V, Bragazzi MC, Carpino G, Torrice A, Fraveto A, Gentile R, Pasqualino V, Melandro F, Aliberti C, Bastianelli C, et al: Cholangiocarcinoma: increasing burden of classifications. Hepatobiliary Surg Nutr 2013, 2:272-280.

19. Cescon M, Ercolani G, Cucchetti A, Ravaioli M, Pinna AD: Is really full right full left split liver transplantation a valuable tool to increase organ availability? Hepatobiliary Surg Nutr 2013, 2:182-183.

20. Chan A: Liver transplantation for unresectable colorectal liver metastasis. Hepatobiliary Surg Nutr 2013, 2:162-164.

21. Chan SC, Fan ST: Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation. Hepatobiliary Surg Nutr 2013, 2:84-88.

22. Chiba T, Kanai F, Iwama A, Yokosuka O: Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:4-6.

23. Franchitto A, Onori P, Renzi A, Carpino G, Mancinelli R, Alvaro D, Gaudio E: Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases. Hepatobiliary Surg Nutr 2013, 2:68-77.

24. Francis T, Graf A, Hodges K, Kennedy L, Hargrove L, Price M, Kearney K, Francis H: Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings. Hepatobiliary Surg Nutr 2013, 2:216-226.

25. Fung J, Lai CL, Yuen MF, Ng IO: Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?Hepatobiliary Surg Nutr 2013, 2:34-36.

26. Girometti R, Baccarani U: Magnetic resonance cholangiopancreatography in assessing living liver donors biliary anatomy: opportunities and challenges. Hepatobiliary Surg Nutr 2013, 2:165-167.

27. Guglielmi A, Ruzzenente A, Bertuzzo F, Iacono C: Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary Surg Nutr 2013, 2:281-283.

28. Guo Z, Lu Y: Organ transplantation is getting back its "true" luster in China. Hepatobiliary Surg Nutr 2013, 2:304-306.

29. Hammerich L, Tacke F: Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by beta-carotene. Hepatobiliary Surg Nutr 2013, 2:248-251.

30. He VJ: Professor Pierce Chow: neo-adjuvant and adjuvant therapy for hepatocellular carcinoma-current evidence. Hepatobiliary Surg Nutr 2013, 2:239-241.

31. He VJ: Professor Henri Bismuth: the past, present and future of hepatobiliary surgery. Hepatobiliary Surg Nutr 2013, 2:236-238.

32. He VJ: Professor Timothy Pawlik: what have we achieved in hilar cholangiocarcinoma over the past decade? Hepatobiliary Surg Nutr 2013, 2:179-181.

33. Hshieh TT, Sundaram V: Liver transplantation for hepatocellular carcinoma: are international guidelines possible?Hepatobiliary Surg Nutr 2013, 2:113-116.

34. Kalthoff M: Saving private healthcare after the verdict. Hepatobiliary Surg Nutr 2013, 2:40-50.

35. Khan SA, Matthews JB: Intraoperative margin re-resection for colorectal cancer liver metastases. Hepatobiliary Surg Nutr 2013, 2:108-112.

36. Lu X, Li Y, Yang H, Sang X, Zhao H, Xu H, Du S, Xu Y, Chi T, Zhong S, et al: Improvement of nutritional support strategies after surgery for benign liver tumor through nutritional risk screening: a prospective, randomized, controlled, single-blind clinical study. Hepatobiliary Surg Nutr 2013, 2:14-21.

37. Makuuchi M, Tamura S, Sugawara Y: New national policy for deceased organ donation in China. Hepatobiliary Surg Nutr 2013, 2:307-308.

38. Mao Y: Multiple disciplinary consensus on perioperative management of overwhelming inflammation for patients undergoing liver resection: an interpretation. Hepatobiliary Surg Nutr 2013, 2:174-175.

39. Mao Y, Sang X: Multiple liver lesions with dormant submandibular gland nodule. Hepatobiliary Surg Nutr 2013, 2:284-285.

40. Mao Y, Sang X: Twenty-eight years of repeated relapse of gastrointestinal stromal tumor. Hepatobiliary Surg Nutr 2013, 2:232-233.

41. Mao Y, Sang X, Liang N, Yang H, Lu X, Yang Z, Du S, Xu Y, Zhao H, Zhong S, et al: Peripheral primitive neuroectodermal tumors arising in the pancreas: the first case report in Asia and a review of the 14 total reported cases in the world. Hepatobiliary Surg Nutr 2013, 2:51-60.

42. Marino D, Colombi F, Ribero D, Aglietta M, Leone F: Targeted agents: how can we improve the outcome in biliary tract cancer? Hepatobiliary Surg Nutr 2013, 2:31-33.

43. Maroni L, Pierantonelli I, Benedetti A, Marzioni M: Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells. Hepatobiliary Surg Nutr 2013, 2:61-64.

44. Mehta SR, Kuo A: Risk stratification for Hepatitis B treatment in the molecular age. Hepatobiliary Surg Nutr 2013, 2:129-131.

45. Melendez-Martinez AJ, Nascimento AF, Wang Y, Liu C, Mao Y, Wang XD: Effect of tomato extract supplementation against high-fat diet-induced hepatic lesions. Hepatobiliary Surg Nutr 2013, 2:198-208.

46. Millis JM: Engagement vs. isolationism: China's transplant system. Hepatobiliary Surg Nutr 2013, 2:295-296.

47. Nascimento AF, Ip BC, Luvizotto RA, Seitz HK, Wang XD: Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats. Hepatobiliary Surg Nutr 2013, 2:252-259.

48. Nishikawa H, Osaki Y: Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:168-170.

49. Peng HC, Chen YL, Yang SY, Ho PY, Yang SS, Hu JT, Yang SC: The antiapoptotic effects of different doses of beta-carotene in chronic ethanol-fed rats. Hepatobiliary Surg Nutr 2013, 2:132-141.

50. Prieto PA, Cha CH: DKK1 as a serum biomarker for hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:127-128.

51. Ragab A, Lopez-Soler RI, Oto A, Testa G: Correlation between 3D-MRCP and intra-operative findings in right liver donors. Hepatobiliary Surg Nutr 2013, 2:7-13.

52. Saied A, Katz SC, Espat NJ: Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases. Hepatobiliary Surg Nutr 2013, 2:97-107.

53. Sankarankutty AK, Mente ED, Cardoso NM, Castro ESO: T-tube or no T-tube for bile duct anastomosis in orthotopic liver transplantation. Hepatobiliary Surg Nutr 2013, 2:171-173.

54. Smith RJ: Nutrition and metabolism in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:89-96.

55. Song P, Feng X, Zhang K, Song T, Ma K, Kokudo N, Dong J, Tang W: Perspectives on using des-gamma-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China. Hepatobiliary Surg Nutr 2013, 2:227-231.

56. Spirli C, Strazzabosco M: Vascular endothelial growth factors in progenitor cells mediated liver repair. Hepatobiliary Surg Nutr 2013, 2:65-67.

57. Stanford KI, Goodyear LJ: The therapeutic potential of brown adipose tissue. Hepatobiliary Surg Nutr 2013, 2:286-287.

58. Stice CP, Wang XD: Carotenoids and alcoholic liver disease. Hepatobiliary Surg Nutr 2013, 2:244-247.

59. Su IJ, Hsieh WC, Tsai HW, Wu HC: Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection. Hepatobiliary Surg Nutr 2013, 2:37-39.

60. Tai WM, Toh HC: Statins: emerging role in chemoprevention for hepatocellular carcinoma? Hepatobiliary Surg Nutr 2013, 2:117-120.

61. Wan S, Civan J, Rossi S, Yang H: Profiling HBV integrations in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2013, 2:124-126.

62. Wang C, Xu Y, Lu X: Should preoperative biliary drainage be routinely performed for obstructive jaundice with resectable tumor? Hepatobiliary Surg Nutr 2013, 2:266-271.

63. Wang H: Responses to comments on "Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report". Hepatobiliary Surg Nutr 2013, 2:309-310.

64. Wang H, Jiang W, Zhou Z, Long J, Li W, Fan ST: Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Hepatobiliary Surg Nutr 2013, 2:188-197.

65. Xu EX: Professor Ronald W. Busuttil: my opinion about the national program for diseased organ donation in China. Hepatobiliary Surg Nutr 2013, 2:311-313.

66. Yano Y, Seo Y, Azuma T, Hayashi Y: Hepatitis B virus and host factors. Hepatobiliary Surg Nutr 2013, 2:121-123.

67. Zavaglia C, Mancuso A, Foschi A, Rampoldi A: High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments? Hepatobiliary Surg Nutr 2013, 2:184-187.

68. Zhan P, Ji YN, Yu LK: TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis. Hepatobiliary Surg Nutr 2013, 2:260-265.

69. Zhan P, Qian Q, Yu LK: Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr 2013, 2:209-215.

70. Zhan P, Qian Q, Yu LK: Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis. Hepatobiliary Surg Nutr 2013, 2:148-155.

71. Zhang Y, Chen J, Wu J, Chalson H, Merigan L, Mitchell A: Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr 2013, 2:142-147.

72. Zhang Y, Kang S, Fang W, Wu X, Liang W: Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation. Hepatobiliary Surg Nutr 2013, 2:297-303.

73. Zhao H: China's surgical expert consensus on the diagnosis and treatment of cholangiocarcinoma: an interpretation. Hepatobiliary Surg Nutr 2013, 2:288-289.

74. Zhao H, Xu Y, Mao Y, Zhang Y: Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells. Hepatobiliary Surg Nutr 2013, 2:78-83.

75. Zheng ES: Professor Javier C. Lendoire: colorectal liver metastases. Hepatobiliary Surg Nutr 2013, 2:292-294.

76. Zheng ES: Professor William Jarnagin: biliary malignancy. Hepatobiliary Surg Nutr 2013, 2:290-291.

77. Zheng ES: Professor James Garden: my experiences and opinions of laparoscopic surger. Hepatobiliary Surg Nutr 2013, 2:176-178.

78. Zhong NQ: Prof. Anita S. Chong: focused research in transplantation tolerance. Hepatobiliary Surg Nutr 2013, 2:314-315.

79. Zhong S: China's expert consensus on laparoscopic liver resection and guidelines on surgical procedures: an interpretation. Hepatobiliary Surg Nutr 2013, 2:234-235.

Publications in 2014
80. Azoulay D, Maggi U, Lim C, Malek A, Compagnon P, Salloum C, Laurent A: Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: a new technique for central tumors. Hepatobiliary Surg Nutr 2014, 3:149-153.

81. Bartneck M, Warzecha KT, Tacke F: Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr 2014, 3:364-376.

82. Bieghs V, Trautwein C: Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 2014, 3:377-385.

83. Boyko VV, Pisetska ME, Tyshchenko OM, Skoryi DI, Kozlova TV, Gorgol NI, Volchenko IV: Role of ischemic preconditioning in hepatic ischemia-reperfusion injury. Hepatobiliary Surg Nutr 2014, 3:179-184.

84. Buonaguro L: TIE2-expressing monocytes: a possible cellular diagnostic and prognostic biomarker for hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014, 3:419-420.

85. Chi T, Xu Y, Lu X: Obstructive jaundice suspected hilar cholangiocarcinoma. Hepatobiliary Surg Nutr 2014, 3:102-103.

86. Chi T, Zheng Y, Lu X: Double carcinomas simultaneously identified in biliary system. Hepatobiliary Surg Nutr 2014, 3:154-155.

87. Clermonts SH, van Dam RM: Obstructive putty-like cast of the biliary tree. Hepatobiliary Surg Nutr 2014, 3:47-49.

88. Coelho JC, Ramos EJ, da Costa MA, Pissaia A, Junior CA, Ivantes: Liver transplantation in a patient with complex anomaly of the inferior vena cava. Hepatobiliary Surg Nutr 2014, 3:212-215.

89. Dapas B, Grassi M, Grassi G: Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Hepatobiliary Surg Nutr 2014, 3:175-178.

90. Eiro N, Vizoso FJ: Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014, 3:98-101.

91. Eshkenazy R, Dreznik Y, Lahat E, Zakai BB, Zendel A, Ariche A: Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr 2014, 3:303-312.

92. Facciorusso A, Antonino M, Del Prete V, Neve V, Scavo MP, Barone M: Are hematopoietic stem cells involved in hepatocarcinogenesis? Hepatobiliary Surg Nutr 2014, 3:199-206.

93. Facciorusso A, Barone M: Glucose intolerance and hepatocellular carcinoma: recent findings for old diseases. Hepatobiliary Surg Nutr 2014, 3:91-92.

94. Fatourou EM, Tsochatzis EA: ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014, 3:415-418.

95. Germano D, Daniele B: TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatobiliary Surg Nutr 2014, 3:166-167.

96. Glaser S, Han Y, Francis H, Alpini G: Melatonin regulation of biliary functions. Hepatobiliary Surg Nutr 2014, 3:35-43.

97. Gonzalez SA: Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived? Hepatobiliary Surg Nutr 2014, 3:410-414.

98. Guerrier M, Attili F, Alpini G, Glaser S: Prolonged administration of secretin to normal rats increases biliary proliferation and secretin-induced ductal secretory activity. Hepatobiliary Surg Nutr 2014, 3:118-125.

99. Harding JJ, Abou-Alfa GK: Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit? Hepatobiliary Surg Nutr 2014, 3:168-171.

100. He VJ: Professor Carlos Eduardo R. Santos: my experiences with liver metastases of sarcoma. Hepatobiliary Surg Nutr 2014, 3:163-164.

101. He VJ: Professor Norbert Huser: the function of immune cells for liver regeneration after partial hepatectomy. Hepatobiliary Surg Nutr 2014, 3:52-54.

102. Hoffer LJ, Bistrian BR: What is the best nutritional support for critically ill patients? Hepatobiliary Surg Nutr 2014, 3:172-174.

103. Hu RT, Wang NY, Huang MJ, Huang CS, Chen DS, Yang SS: Multiple variants in UGT1A1 gene are factors to develop indirect hyper-bilirubinemia. Hepatobiliary Surg Nutr 2014, 3:194-198.

104. Karamarkovic A, Doklestic K: Pre-resectional inflow vascular control: extrafascial dissection of Glissonean pedicle in liver resections. Hepatobiliary Surg Nutr 2014, 3:227-237.

105. Kauffmann R, Fong Y: Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 2014, 3:238-246.

106. Kim CH: Hidden secret in hepatitis B viral X protein mutation and hypoxia-inducible factor-1alpha in hepatocarcinoma cancer. Hepatobiliary Surg Nutr 2014, 3:115-117.

107. Kluger MD: Laparoscopic liver resection: basic skills for peripheral lesions. Hepatobiliary Surg Nutr 2014, 3:44-46.

108. Kopljar M, Patrlj L, Busic Z, Kolovrat M, Rakic M, Klicek R, Zidak M, Stipancic I: Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer. Hepatobiliary Surg Nutr 2014, 3:259-267.

109. Krenkel O, Mossanen JC, Tacke F: Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr 2014, 3:331-343.

110. Lahat E, Eshkenazy R, Zendel A, Zakai BB, Maor M, Dreznik Y, Ariche A: Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr 2014, 3:317-323.

111. Lee YJ, Jang BK: Can combination of osteopontin and peritumor-infiltrating macrophages be a prognostic marker of early-stage hepatocellular carcinoma? Hepatobiliary Surg Nutr 2014, 3:57-59.

112. Lee YY, Mok MT, Cheng AS: Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014, 3:95-97.

113. Leung U, Fong Y: Robotic liver surgery. Hepatobiliary Surg Nutr 2014, 3:288-294.

114. Li H, Zhou X, Ying D, Zheng S: Laparoscopic pancreaticoduodenectomy. Hepatobiliary Surg Nutr 2014, 3:421-422.

115. Li Y, Wongsiriroj N, Blaner WS: The multifaceted nature of retinoid transport and metabolism. Hepatobiliary Surg Nutr 2014, 3:126-139.

116. Liang KH, Yeh CT: OPN sesame. Hepatobiliary Surg Nutr 2014, 3:112-114.

117. Liao M, Huang J, Wu H, Zeng Y: Shall we take a second thought before applying radiofrequency ablation for resectable HCC </=2 cm? Hepatobiliary Surg Nutr 2014, 3:109-111.

118. Liu CY, Feng GS: NCOA5, a molecular link between type 2 diabetes and liver cancer. Hepatobiliary Surg Nutr 2014, 3:106-108.

119. Malaguarnera G, Bertino G, Vacante M, Malaguarnera M: Hepatocellular carcinoma markers in the omics era: the glycomic analysis. Hepatobiliary Surg Nutr 2014, 3:407-409.

120. Mao Y, Sang X: Large liver mass in a patient with latent colon cancer. Hepatobiliary Surg Nutr 2014, 3:50-51.

121. Matrella F, Lhuaire M, Piardi T, Dokmak S, Bruno O, Maestraggi Q, Kianmanesh R, Sommacale D: Liver hilar abscesses secondary to gastrointestinal perforation by ingested fish bones: surgical management of two cases. Hepatobiliary Surg Nutr 2014, 3:156-162.

122. Neri F, Ravaioli M, Pinna AD: The multiple aspects of liver transplantation for hepatocellular carcinoma: comments on the recommendations from the consensus conference. Hepatobiliary Surg Nutr 2014, 3:1-3.

123. Nomoto S, Hishida M, Inokawa Y, Sugimoto H, Kodera Y: Management of hepatocellular carcinoma should consider both tumor factors and background liver factors. Hepatobiliary Surg Nutr 2014, 3:82-85.

124. Patrlj L, Kopljar M, Fong Y: Maturation of HBP surgery: worldwide advances to address worldwide problems. Hepatobiliary Surg Nutr 2014, 3:219-220.

125. Patrlj L, Kopljar M, Klicek R, Patrlj MH, Kolovrat M, Rakic M, Duzel A: The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary Surg Nutr 2014, 3:324-329.

126. Piardi T, Sommacale D, Baumert T, Mutter D, Marescaux J, Pessaux P: Laparoscopic resection for hepatocellular carcinoma: comparison between Middle Eastern and Western experience. Hepatobiliary Surg Nutr 2014, 3:60-72.

127. Rakic M, Patrlj L, Klicek R, Kopljar M, Duzel A, Cupurdija K, Busic Z: The laparoscopic liver resections-an initial experience and the literature review. Hepatobiliary Surg Nutr 2014, 3:313-316.

128. Rakic M, Patrlj L, Kopljar M, Klicek R, Kolovrat M, Loncar B, Busic Z: Gallbladder cancer. Hepatobiliary Surg Nutr 2014, 3:221-226.

129. Renzi A, Mancinelli R, Onori P, Franchitto A, Alpini G, Glaser S, Gaudio E: Inhibition of the liver expression of arylalkylamine N-acetyltransferase increases the expression of angiogenic factors in cholangiocytes. Hepatobiliary Surg Nutr 2014, 3:4-10.

130. Ryska M, Rudis J: Pancreatic fistula and postoperative pancreatitis after pancreatoduodenectomy for pancreatic cancer. Hepatobiliary Surg Nutr 2014, 3:268-275.

131. Schoellhammer HF, Fong Y, Gagandeep S: Techniques for prevention of pancreatic leak after pancreatectomy. Hepatobiliary Surg Nutr 2014, 3:276-287.

132. Schon HT, Weiskirchen R: Immunomodulatory effects of transforming growth factor-beta in the liver. Hepatobiliary Surg Nutr 2014, 3:386-406.

133. Seliman H: Professor Lei Zheng: Multidisciplinary management for pancreatic cancer. Hepatobiliary Surg Nutr 2014, 3:216-218.

134. Shaikh F, Goff LW: Decoding hepatocellular carcinoma: the promise of microRNAs. Hepatobiliary Surg Nutr 2014, 3:93-94.

135. She WH, Cheung TT, Yau TC, Chan AC, Chok KS, Chu FS, Liu RK, Poon RT, Chan SC, Fan ST, Lo CM: Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection. Hepatobiliary Surg Nutr 2014, 3:185-193.

136. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM: Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr 2014, 3:18-34.

137. Soggiu F, Marescaux J, Pessaux P: Intrahepatic pseudoaneurysm after radiofrequency ablation of liver metastases. Hepatobiliary Surg Nutr 2014, 3:207-208.

138. Soler L, Nicolau S, Pessaux P, Mutter D, Marescaux J: Real-time 3D image reconstruction guidance in liver resection surgery. Hepatobiliary Surg Nutr 2014, 3:73-81.

139. Sun Y, Yang Z, Tan H: Perioperative nutritional support and fluid therapy in patients with liver diseases. Hepatobiliary Surg Nutr 2014, 3:140-148.

140. Tacke F, Weiskirchen R: Liver immunology: new perspectives. Hepatobiliary Surg Nutr 2014, 3:330.

141. Tamura S, Sugawara Y: Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth. Hepatobiliary Surg Nutr 2014, 3:55-56.

142. Weiskirchen R, Tacke F: Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 2014, 3:344-363.

143. Xu EX: To learn and to share: Hepatobiliary, Pancreatic Surgery and Manuscript Writing Symposium. Hepatobiliary Surg Nutr 2014, 3:425-427.

144. Xu EX: Living legend in surgery: Professor Roger Williams. Hepatobiliary Surg Nutr 2014, 3:423-424.

145. Xu EX: Professor Real Lapointe: the impact of portal embolization on postoperative morbidity and mortality after liver resection. Hepatobiliary Surg Nutr 2014, 3:104-105.

146. Yeh YT, Dai HY, Chien CY: Amplification of MPZL1/PZR gene in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014, 3:87-90.

147. Yucesoy AN, Pocan S: Secondary gallbladder hydatidosis and nonfragmanted germinative membrane sourced obstructive jaundice caused by intrabiliary ruptured hepatic hydatid cyst (a case report): two rare complication of the intrabiliary ruptured hepatic hydatid cyst. Hepatobiliary Surg Nutr 2014, 3:209-211.

148. Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A: "Vanishing liver metastases"-A real challenge for liver surgeons. Hepatobiliary Surg Nutr 2014, 3:295-302.

149. Zhan P, Ji YN: Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr 2014, 3:11-17.

150. Zovak M, Muzina Misic D, Glavcic G: Pancreatic surgery: evolution and current tailored approach. Hepatobiliary Surg Nutr 2014, 3:247-258.

Pulications in 2015

151. Churin Y, Roderfeld M, Roeb E. Hepatitis B virus large surface protein: function and fame. HepatoBiliary Surg Nutr 2015;4(1):1-10.

152. Ramadori P, Kroy D, Streetz KL. Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.HepatoBiliary Surg Nutr 2015;4(1):11-23.

153. Roy S, Benz F, Luedde T, Roderburg C. The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis. HepatoBiliary Surg Nutr 2015;4(1):24-33

154. Xu J, Cong M, Park TJ, Scholten D, Brenner DA, Kisseleva T. Contribution of bone marrow-derived fibrocytes to liver fibrosis. HepatoBiliary Surg Nutr 2015;4(1):34-47.

155. Best J, Manka P, Syn WK, Dollé L, van Grunsven LA, Canbay A. Role of liver progenitors in liver regeneration. HepatoBiliary Surg Nutr 2015;4(1):48-58.

156. Afaneh C, Gerszberg D, Slattery E, Seres DS, Chabot JA, Kluger MD. Pancreatic cancer surgery and nutrition management: a review of the current literature. HepatoBiliary Surg Nutr 2015;4(1):59-71.

157. Beppu T, Sakamoto Y, Hayashi H, Baba H. Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastases. HepatoBiliary Surg Nutr 2015;4(1):72-75.

158. Mulherin DW, Sacks GS. Uncertainty about the safety of supplemental glutamine: an editorial on “A randomized trial of glutamine and antioxidants in critically ill patients”. HepatoBiliary Surg Nutr 2015;4(1):76-79.

159. Padmanabhan C, Parikh A. Perioperative chemotherapy for resectable colorectal hepatic metastases—What does the EORTC 40983 trial update mean? HepatoBiliary Surg Nutr 2015;4(1):80-83.

160. Losada H, Hirsch M, Guzmán P, Fonseca F, Hofmann E, Alanís M. Fascioliasis simulating an intrahepatic cholangiocarcinoma—Case report with imaging and pathology correlation. HepatoBiliary Surg Nutr 2015;4(1):E1-E7.

161. Meschino M, García-Ochoa C, Hernandez-Alejandro R. Ruptured choledochal cyst: a rare presentation and unique approach to management. HepatoBiliary Surg Nutr 2015;4(1):E8-E12.

162. Wang XD,Seitz HK. Fatty liver disease and nutrient intervention. HepatoBiliary Surg Nutr 2015;4(2):86-87.

163. You M,Jogasuria A, Taylor C, Wu J. Sirtuin 1 signaling and alcoholic fatty liverdisease. HepatoBiliary Surg Nutr 2015;4(2):88-100.

164. Bhatt HB,Smith RJ. Fatty liver disease in diabetes mellitus. HepatoBiliary Surg Nutr 2015;4(2):101-108.

165. Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. HepatoBiliary Surg Nutr 2015;4(2):109-116.

166. Linhart KB,Glassen K, Peccerella T, Waldherr R, Linhart H, Bartsch H, Seitz HK. Thegeneration of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. HepatoBiliary Surg Nutr 2015;4(2):117-123.

167. Rafacho BP,Stice CP, Liu C, Greenberg AS, Ausman LM, Wang XD. Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin1 activity in mice. HepatoBiliary Surg Nutr 2015;4(2):124-134.

168. Editorial Office. Where will the China’s organ transplantation move towards? HepatoBiliary Surg Nutr 2015;4(2):135. 

169. Danovitch GM, Delmonico FL. China on the brink: there is hope for the end of their use of executed prisoner organs.HepatoBiliary Surg Nutr 2015;4(2):136-137.

170. Jha V. Reforms in organ donation in China: still to be executed? HepatoBiliary Surg Nutr 2015;4(2):138-140.

171. García-Gallont R. Organ procurement from executed prisoners in China. HepatoBiliary Surg Nutr 2015;4(2):141. 

172. Martin DE, Tibell A. Implementation of China’s new policies on organ procurement: an important but challenging step forward. HepatoBiliary Surg Nutr 2015;4(2):142-144.

173. Guo Z, Lu X,Che L. A dream comes true and a new journey begins. HepatoBiliary Surg Nutr 2015;4(2):145-146.

174. Seitz HK, Mueller S, Hellerbrand C, Liangpunsakul S. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). HepatoBiliary Surg Nutr 2015;4(3):147-151. 

175. Stickel F, Hampe J, Trépo E, Datz C, Romeo S. PNPLA3 genetic variation in alcoholic steatosis and liver disease progression. HepatoBiliary Surg Nutr 2015;4(3):152-160.

176. Yilmaz B, Sahin K, Bilen H, Bahcecioglu IH, Bilir B, Ashraf S, Halazun KJ, Kucuk O. Carotenoids and non-alcoholic fatty liver disease. HepatoBiliary Surg Nutr 2015;4(3):161-171. 

177. Chen YL, Peng HC, Wang XD, Yang SC. Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats. HepatoBiliary Surg Nutr 2015;4(3):172-183. 

178. Yuen JJ, Lee SA, Jiang H, Brun PJ, Blaner WS. DGAT1-deficiency affects the cellular distribution of hepatic retinoid and attenuates the progression of CCl4-induced liver fibrosis. HepatoBiliary Surg Nutr 2015;4(3):184-196. 

179. Huang YW, Chayama K, Kao JH, Yang SS. Detectability and clinical significance of serum hepatitis B virus ribonucleic acid. HepatoBiliary Surg Nutr 2015;4(3):197- 202. 

180. Cieslak KP, Bennink RJ, van Gulik TM. Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using 99mTc-GSA SPECT/CT. HepatoBiliary Surg Nutr 2015;4(3):203-205. 

181. Baffy G. Decoding multifocal hepatocellular carcinoma: an opportune pursuit. HepatoBiliary Surg Nutr 2015;4(3):206-210. 

182. Martin RC II. Use of irreversible electroporation in unresectable pancreatic cancer. HepatoBiliary Surg Nutr 2015;4(3):211-215. 

183. Benatta MA, Barthet M, Desjeux A, Grimaud JC. Endoscopic extraction of biliary stones and a migrated endoclip for acute pancreatitis. HepatoBiliary Surg Nutr 2015;4(3):216-217. 

184. de Werra E, Ettorre GM, Levi Sandri GB, Colasanti M, Felli E, Vennarecci G. Major hepatectomy for a symptomatic giant liver cavernous hemangioma. HepatoBiliary Surg Nutr 2015;4(3):218-219. 

185. Wongsiriroj N, Blaner WS. The diversity of retinoid biology. HepatoBiliary Surg Nutr 2015;4(4):220-221. 

186. Shirakami Y, Sakai H, Shimizu M. Retinoid roles in blocking hepatocellular carcinoma. HepatoBiliary Surg Nutr 2015;4(4):222-228. 

187. Kelly M, von Lintig J. STRA6: role in cellular retinol uptake and efflux. HepatoBiliary Surg Nutr 2015;4(4):229-242. 

188. Shmarakov IO. Retinoid-xenobiotic interactions: the Ying and the Yang. HepatoBiliary Surg Nutr 2015;4(4):243-267. 

189. Kim YK, Zuccaro MV, Zhang C, Sarkar D, Quadro L. Alcohol exposure in utero perturbs retinoid homeostasis in adult rats. HepatoBiliary Surg Nutr 2015;4(4):268-277. 

190. Bengmark S. Obesity, the deadly quartet and the contribution of the neglected daily organ rest - a new dimension of un-health and its prevention. HepatoBiliary Surg Nutr 2015;4(4):278-288. 

191. Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. HepatoBiliary Surg Nutr 2015;4(4):289-292. 

192. Pineda-Solis K, McAlister V. Wading through the noise of “multi-omics” to identify prognostic biomarkers in hepatocellular carcinoma. HepatoBiliary Surg Nutr 2015;4(4):293-294. 

193. Benatta MA, Loumi A. Oesophagogastric junction stricture: a rare complication of chemotherapy for malignant lymphoma. HepatoBiliary Surg Nutr 2015;4(4):295-296. 

194. Rajesh S, Sarda P, Bihari C. Undifferentiated (embryonal) sarcoma of liver. HepatoBiliary Surg Nutr 2015;4(4):297-298. 

195. Ariche A, Klein Y, Cohen A, Lahat E. Major hepatectomy for complex liver trauma. HepatoBiliary Surg Nutr 2015;4(4):299-302. 

196. Xu EX. Living legend in surgery: Professor Masatoshi Makuuchi. HepatoBiliary Surg Nutr 2015;4(4):303. 

197. Liu Y, Xue X. Systematic review of peri-operative nutritional support for patients undergoing hepatobiliary surgery. HepatoBiliary Surg Nutr 2015;4(5):304- 312. 

198. Tsunashima H, Tsuneyama K, Moritoki Y, Hara M, Kikuchi K. Accumulated myeloid-derived suppressor cells demonstrate distinct phenotypes and functions in two non- alcoholic steatohepatitis mouse models. HepatoBiliary Surg Nutr 2015;4(5):313-319. 

199. Ettorre GM, Levi Sandri GB, Santoro R, Vennarecci G, Lepiane P, Colasanti M, Felli E, de Werra E, Colace L, D’Offizi G, Montalbano M, Visco U, Maritti M, Antonini M, Santoro E. Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: single center experience of 90 cases. HepatoBiliary Surg Nutr 2015;4(5):320- 324. 

200. Ansari D, Ansari D, Andersson R, Andrén-Sandberg Å. Pancreatic cancer and thromboembolic disease, 150 years after Trousseau. HepatoBiliary Surg Nutr 2015;4(5):325-335. 

201. Zhang QK, Wang ML. The management of perioperative nutrition in patients with end stage liver disease undergoing liver transplantation. HepatoBiliary Surg Nutr 2015;4(5):336-344. 

202. Levi Sandri GB, Colace L, Vennarecci G, Santoro R, Lepiane P, Colasanti M, Burocchi M, Ettorre GM. Laparoscopic first step approach in the two stage hepatectomy. HepatoBiliary Surg Nutr 2015;4(5):345-347. 

203. Hsieh J, Thosani A, Grunwald M, Nagula S, Bucobo JC, Buscaglia JM. Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients. HepatoBiliary Surg Nutr 2015;4(5):348-353. 

204. Veerankutty FH, Yeldho V, TU SA, Venugopal B, Manoj KS, Vidhya C. Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature. HepatoBiliary Surg Nutr 2015;4(5):354- 362. 

205. Spolverato G, Montgomery E, Kamel I, Pawlik TM. Endometrial stromal sarcoma presenting as large bleeding left upper quadrant mass. HepatoBiliary Surg Nutr 2015;4(5):363-366. 

206. Pandey D, Garg PK, Jakhetiya A, Sharma J, Chandrashekhara SH. Markedly elevated liver transaminases following pancreaticoduodenectomy: celiac artery thrombosis in disguise. HepatoBiliary Surg Nutr 2015;4(5):367-368. 

207. Romic I, Pavlek G. Ankle metastasis as a sign of intrahepatic cholangiocellular carcinoma. HepatoBiliary Surg Nutr 2015;4(5):369-370.